DUCKWORTH & KENT LTD LENS DELIVERY SYSTEM
K024072 · Duckworth & Kent, Ltd. · MSS · Oct 6, 2003 · Ophthalmic
Device Facts
| Record ID | K024072 |
| Device Name | DUCKWORTH & KENT LTD LENS DELIVERY SYSTEM |
| Applicant | Duckworth & Kent, Ltd. |
| Product Code | MSS · Ophthalmic |
| Decision Date | Oct 6, 2003 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 886.4300 |
| Device Class | Class 1 |
| Attributes | Therapeutic |
Intended Use
Folding and injection of Chiron Softex LI61U lens implant into the eye using a Chiron Microsert IC-5BU disposable cartridge.
Device Story
The Duckworth & Kent Ltd Lens Delivery System DK7782-1 is a manual surgical instrument designed for the folding and injection of the Chiron Softex LI61U intraocular lens (IOL) implant. The device functions as a guide/delivery system, facilitating the insertion of the IOL into the eye through a small incision. It is intended for use by ophthalmic surgeons in a clinical or operating room setting. The device operates in conjunction with the Chiron Microsert IC-5BU disposable cartridge, which holds the lens during the delivery process. By enabling controlled folding and injection, the system assists the surgeon in placing the lens implant accurately, potentially reducing surgical trauma and improving patient outcomes during cataract or refractive lens exchange procedures.
Clinical Evidence
Bench testing only.
Technological Characteristics
Manual surgical instrument; classified as an intraocular lens guide (21 CFR 886.4300). Designed for use with specific disposable cartridges (Chiron Microsert IC-5BU) for IOL delivery. No electronic, software, or energy-based components.
Indications for Use
Indicated for the folding and injection of the Chiron Softex LI61U lens implant into the eye during ophthalmic surgery, utilizing the Chiron Microsert IC-5BU disposable cartridge.
Regulatory Classification
Identification
An intraocular lens guide is a device intended to be inserted into the eye during surgery to direct the insertion of an intraocular lens and be removed after insertion is completed.
Related Devices
- K053176 — DUCKWORTH & KENT LTD CARTRIDGE LENS DELIVERY SYSTEM, MODEL DK7797 · Duckworth & Kent, Ltd. · Jan 30, 2006
- K060995 — DUCKWORTH & KENT LTD LENS DELIVERY SYSTEM, MODEL DK7788 · Duckworth & Kent, Ltd. · May 22, 2006
- K082944 — CRYSTALSERT CRYSTALENS DELIVERY SYSTEM · Bausch & Lomb, Inc. · Oct 16, 2008
- K122848 — LENSTEC LC INJECTION SYSTEM · Lenstec, Inc. · Oct 18, 2013
- K132481 — EASY-LOAD LENS DELIVERY SYSTEM · Bausch & Lomb · Dec 27, 2013
Submission Summary (Full Text)
{0}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or a stylized human figure, composed of three curved lines.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT - 6 2003
Duckworth & Kent, Ltd. c/o Mr. Martin Lock Terence House 7 Marquis Business Centre Royston Road Baldock, Herts, SG7 6XL England
Re: K024072
Trade/Device Name: Duckworth & Kent Ltd Lens Delivery System DK7782-1 Regulation Number: 21 CFR 886.4300 Regulation Name: Intraocular lens guide Regulatory Class: Class I Product Code: MSS Dated: July 18, 2003 Received: July 21, 2003
Dear Mr. Lock:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{1}------------------------------------------------
Page 2 - Mr. Martin Lock
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
A helyi Rosenthal
A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
## STATEMENT OF INDICATIONS FOR USE
510K Number (if known): K024072
Device Name: Duckworth & Kent Ltd Lens Delivery System DK7782-1
Indications for Use:
Folding and injection of Chiron Softex LI61U lens implant into the eye using a Chiron Microsert IC-5BU disposable cartridge.
Indications for Use Labelling:
## INDICATION FOR USE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Folding and Inlection of Chiron Soflex L161U lens Implant into the eye using a Chiron Microsert IC-5BU disposable carridge.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
R.P. Jr.
Division Sign-Off Division of Ophthalmic Ear, Nose and Throat Devises
510(k) Number K024072